Fresh Recalls

FDAClass II · Drug · Recall D-0538-2026 · Recalled May 27, 2026

Atomoxetine Capsules HCL recall — Safecor Health, LLC

Agency report date: May 27, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Atomoxetine Capsules HCL
Company / brand
Safecor Health
Lot / serial / date codes
Lot #: 25530722
Distribution
TX only
Agency product description and boundaries

Atomoxetine Capsules HCL, 10 mg Capsules in unit dose foil strip, strips are packed in cartons of 100, Rx Only, Pkg by: Safecor, Columbus, OH 43204. NDC: 64380-474-01

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Labeling: Label Mix-Up: Atomoxetine HCl 25mg Capsule incorrectly labeled as Atomoxetine HCl 10mg Capsule.

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Atomoxetine Capsules HCL recall status

3. Open the official notice or contact

Official recall ID
D-0538-2026
Brand
All Safecor Health recalls
Classification
Class II
Units affected
149 capsules
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Columbus, OH, United States
Firm address
4060 Business Park Dr Ste B, 43204-5047

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 25530722
Distribution
TX only
Firm notified the public via
E-Mail
FDA event ID
98885
Recall initiated
April 30, 2026
FDA classified
May 18, 2026
FDA report date
May 27, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 6:00 PM UTC. Record retrieved August 25, 2026 at 6:00 PM UTC.

Report a data error on this page